C4 Therapeutics (CCCC) Prepaid Assets (2019 - 2026)

C4 Therapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $6.8 million for Q1 2026.

• On a quarterly basis, Prepaid Assets fell 27.63% year-over-year to $6.8 million in Q1 2026; TTM through Mar 2026 was $6.8 million, a 27.63% decrease from a year earlier, with the FY2025 full-year figure at $7.2 million, down 26.52% from the prior year.
• Prepaid Assets retreated to $6.8 million in Q1 2026 per CCCC's latest filing, from $7.2 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $10.8 million in Q2 2024 and bottomed at $5.7 million in Q4 2023.
• The 5-year median for Prepaid Assets is $8.0 million (2025), against an average of $8.3 million.
• Across the five-year window, Prepaid Assets soared 105.07% in 2022 and slumped 42.51% in 2023, its largest moves.
• Year by year, Prepaid Assets stood at $9.9 million in 2022, then slumped by 42.51% to $5.7 million in 2023, then surged by 70.98% to $9.8 million in 2024, then declined by 26.52% to $7.2 million in 2025, then declined by 4.95% to $6.8 million in 2026.
• Per Business Quant, the three latest CCCC Prepaid Assets figures stand at $6.8 million (Q1 2026), $7.2 million (Q4 2025), and $8.4 million (Q3 2025).